Adding of apatinib and camrelizumab to overcome de novo trastuzumab resistance of HER2-positive gastric cancer: A case report and literature review by Huifang Lv, Yunduan He, Caiyun Nie, Feng Du, Xiaobing Chen

Connect to this object online.

Tailoring second-line or above therapy for patients with advanced or metastatic gastric cancer: A multicenter real-world study by Caiyun Nie, Caiyun Nie, Caiyun Nie, Caiyun Nie, Weifeng Xu, Weifeng Xu, Weifeng Xu, Weifeng Xu, Huifang Lv, Huifang Lv, Huifang Lv, Huifang Lv, Xiaohui Gao, Guofeng Li, Beibei Chen, Beibei Chen, Beibei Chen, Beibei Chen, Jianzheng Wang, Jianzheng Wang, Jianzheng Wang, Jianzheng Wang, Yingjun Liu, Jing Zhao, Jing Zhao, Jing Zhao, Jing Zhao, Yunduan He, Yunduan He, Yunduan He, Yunduan He, Saiqi Wang, Saiqi Wang, Saiqi Wang, Saiqi Wang, Xiaobing Chen, Xiaobing Chen, Xiaobing Chen, Xiaobing Chen

Connect to this object online.